Panretinal Photocoagulation vs Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy
This randomized clinical trial reports that 5-year visual acuity results were similar in patients treated with panretinal photocoagulation and ranibizumab for proliferative diabetic retinopathy.
Source: JAMA Ophthalmology - Category: Opthalmology Source Type: research
More News: Clinical Trials | Diabetes | Endocrinology | Lucentis | Opthalmology | Ranibizumab Injection